A medtech veteran takes on C.diff: Rebiotix CEO Lee Jones

Clostridium difficile or C. diff. is a growing crisis in the U.S. with over 29,000 deaths and 500,000 cases annually, according to the CDC. The disease, which CDC officials warned can kill people in less than 30 days, is characterized by severe diarrhea, fever, and loss of appetite. Sadly, many elderly and infirmed patients are among the most vulnerable. Roseville, Minn.-based Rebiotix is one of a handful of companies looking to harness the human microbiome into a treatment for recurrent C. diff, which impacts about 20-30% of patients, where there are currently no approved drugs to treat patients with two or more recurrences. Rebiotix is currently in Phase 2 clinical trials for the treatment, which harnesses gut microbiota and turns them into therapies. The company hopes recurrent C. diff is just the 1st in a pipeline of treatments than can be derived from the microbiome. On this episode of DeviceTalks we discuss C.diff with Reviotix CEO Lee Jones. What personal stories led her to this mission; How powerful the human microbiome will be in the future of combating disease and the differences between running a medtech company and a biotech company.

Om Podcasten

The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry. Each episode dives deep into critical areas like business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and beyond. You’ll hear from leading voices at top companies—ranging from major OEMs to innovative startups—sharing their solutions, stories, and strategies for tackling the industry’s biggest challenges. Our Lineup of Shows Includes: • DeviceTalks Weekly • AbbottTalks • Boston Scientific Talks • DeviceTalks AI • IntuitiveTalks • MedtechWOMEN Talks • MedtronicTalks • Neuro Innovation Talks: J&J MedTech Neurovascular • Structural Heart Talks: Edwards Lifesciences • Ortho Innovation Talks: Enovis & Zimmer Biomet • StrykerTalks Why Subscribe? Subscribing here means you’ll never miss an update from any of our shows. Whether you want a broad overview of the entire industry or prefer to tune into a specific series, this single feed has you covered. If you discover a favorite topic, you can always subscribe to that individual show’s feed for a more tailored experience. Meet Your Hosts: • Tom Salemi, Editorial Director, DeviceTalks • Kayleen Brown, Managing Editor, DeviceTalks #DeviceTalks, Where Device Makers Connect.